# Arevipharma GmbH – FDA Inspection, Sep 16, 2019

Source: https://www.keypedia.com/records/fda_inspections/arevipharma-gmbh/d795ea7c-d802-42db-ae9e-0fbc04a1d9ab
Source feed: FDA_Inspections

> FDA inspection 1141793 of Arevipharma GmbH, September 16, 2019. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1141793
- Company Name: Arevipharma GmbH
- Inspection Date: 2019-09-16
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1288700 - 2025-06-20](https://www.keypedia.com/records/fda_inspections/arevipharma-gmbh/c286f0d5-f5e5-4af8-b1d5-56d82a663486)
- FDA Inspection 969875 - 2016-04-29
- FDA Inspection 808573 - 2012-11-16
- FDA Inspection 576014 - 2009-04-08

## Related Officers

- Issuing Officer

Company: https://www.keypedia.com/companies/arevipharma-gmbh/d2cf1bd6-f918-449d-83e7-70065b9cb728

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c